# NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery

> **NCT03020017** · EARLY_PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 8 (actual)

## Conditions studied

- Gliosarcoma
- Recurrent Glioblastoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study
- **DRUG:** Targeted Molecular Therapy

## Key facts

- **NCT ID:** NCT03020017
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-25
- **Primary completion:** 2018-09-06
- **Final completion:** 2020-08-19
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03020017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03020017, "NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03020017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*